Exhibit 99.1  Press Release

HealthRenu Medical, Inc. Secures $10 Million in Funding from Cornell Capital
Partners, LP

HOUSTON, TX--(       )--May 26, 2005--HealthRenu Medical Inc. (OTCBB:HRUM) today
announced that the company has received a financing commitment from Cornell
Capital Partners, LP, a New Jersey based private equity fund. Under the terms of
the funding agreement, Cornell commits to provide up to $10 million under a
Standby Equity Distribution Agreement ("SEDA") over a 24-month period. These
funds can be drawn at the company's discretion based upon funding requirements,
subject to an effective registration with the SEC.

Robert Prokos, President and CEO of HealthRenu Medical, commented, "We are
pleased to enter into this agreement with Cornell Capital. The flexibility and
control afforded by this capital structure will enable us to access capital on
favorable terms to HealthRenu Medical. We have also been very impressed with the
professional manner in which Cornell has conducted itself throughout this
process."

ABOUT HEALTHRENU MEDICAL

HealthRenu Medical is a biotech/healthcare company that specializes in skin and
wound care. Since 1996, the company has been producing breakthrough products
that are an effective and affordable answer to healthcare's major skin related
challenges. The success of these products has been demonstrated in surgical
procedures, nursing homes, hospitals, and hospice care.

ABOUT CORNELL CAPITAL

Managed by US-based Yorkville Advisors LLC, Cornell Capital Partners, LP has
structured equity participation agreements in the U.S., United Kingdom and
Australian financial markets. Cornell is recognized as a world leader in these
types of agreements and has made available in excess of $900 million for close
to 100 publicly quoted corporations. Information regarding Cornell Capital
Partners, LP can be found at www.cornellcapital.com.

SAFE HARBOR STATEMENT

This press release contains information that constitutes forward-looking
statements made pursuant to the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995. Any such forward-looking statements involve risk
and uncertainties that could cause actual results to differ materially from any
future results described within the forward-looking statements. Risk factors
that could contribute to such differences include those matters more fully
disclosed in the Company's reports filed with the Securities and Exchange
Commission. The forward-looking information provided herein represents the
Company's estimates as of the date of the press release, and subsequent events
and developments may cause the Company's estimates to change. The Company
specifically disclaims any obligation to update the forward-looking information
in the future. Therefore, this forward-looking information should not be relied
upon as representing the Company's estimates of its future financial performance
as of any date subsequent to the date of this press release.

CONTACTS:
HealthRenu Medical
(888) 583-3356
(281) 890-2561

Cornell Capital Partners
David Ratzer
(866) 967-5845



                                       1